BRPI0815658A2 - Aril-éter pirrolidina como antagonistas do receptor nk3 - Google Patents
Aril-éter pirrolidina como antagonistas do receptor nk3Info
- Publication number
- BRPI0815658A2 BRPI0815658A2 BRPI0815658-1A2A BRPI0815658A BRPI0815658A2 BR PI0815658 A2 BRPI0815658 A2 BR PI0815658A2 BR PI0815658 A BRPI0815658 A BR PI0815658A BR PI0815658 A2 BRPI0815658 A2 BR PI0815658A2
- Authority
- BR
- Brazil
- Prior art keywords
- pyrolidine
- receptor antagonists
- aryl ether
- aryl
- ether
- Prior art date
Links
- 102000002003 Neurokinin-3 Receptors Human genes 0.000 title 1
- 108010040716 Neurokinin-3 Receptors Proteins 0.000 title 1
- -1 Pyrolidine Aryl Ether Chemical class 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/08—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing alicyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07113942 | 2007-08-07 | ||
| PCT/EP2008/059908 WO2009019163A1 (en) | 2007-08-07 | 2008-07-29 | Pyrrolidine aryl-ether as nk3 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0815658A2 true BRPI0815658A2 (pt) | 2015-02-18 |
Family
ID=39865446
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0815658-1A2A BRPI0815658A2 (pt) | 2007-08-07 | 2008-07-29 | Aril-éter pirrolidina como antagonistas do receptor nk3 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8012998B2 (pt) |
| EP (1) | EP2185540B1 (pt) |
| JP (1) | JP2010535733A (pt) |
| KR (1) | KR101167774B1 (pt) |
| CN (1) | CN101778837A (pt) |
| AR (1) | AR067808A1 (pt) |
| AT (1) | ATE517100T1 (pt) |
| AU (1) | AU2008285718A1 (pt) |
| BR (1) | BRPI0815658A2 (pt) |
| CA (1) | CA2695211A1 (pt) |
| CL (1) | CL2008002293A1 (pt) |
| ES (1) | ES2367464T3 (pt) |
| IL (1) | IL203363A (pt) |
| MX (1) | MX2010001080A (pt) |
| PE (1) | PE20090898A1 (pt) |
| RU (1) | RU2010106974A (pt) |
| TW (1) | TW200916456A (pt) |
| WO (1) | WO2009019163A1 (pt) |
| ZA (1) | ZA201000676B (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2697325A1 (en) * | 2007-08-22 | 2009-02-26 | F. Hoffmann-La Roche Ag | Pyrrolidine aryl-ether as nk3 receptor antagonists |
| KR101372743B1 (ko) | 2009-01-30 | 2014-03-14 | 에프. 호프만-라 로슈 아게 | Ｎｋ3 수용체 길항제로서 피페리딘 유도체 |
| US8318759B2 (en) * | 2009-02-18 | 2012-11-27 | Hoffmann-La Roche Inc. | Pyrrolidine derivatives as NK3 receptor antagonists |
| US8394834B2 (en) * | 2009-08-25 | 2013-03-12 | Hoffman-La Roche Inc. | Pyrrolidines as NK3 receptor antagonists |
| JP2013508350A (ja) * | 2009-10-20 | 2013-03-07 | ファイザー・インク | ガンマ−セクレターゼモジュレーターとしての新規なヘテロアリールイミダゾールおよびヘテロアリールトリアゾール |
| US8507535B2 (en) | 2010-07-07 | 2013-08-13 | Hoffmann-La Roche Inc. | Methyl-pyrrolidine ether derivatives |
| EP3183248B1 (en) | 2014-08-21 | 2020-11-11 | Bristol-Myers Squibb Company | Tied-back benzamide derivatives as potent rock inhibitors |
| CA3015702A1 (en) | 2015-09-02 | 2017-03-09 | Trevena, Inc. | 6-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same |
| WO2017072629A1 (en) | 2015-10-29 | 2017-05-04 | Cadila Healthcare Limited | Pharmaceutical combination of nk3 receptor antagonist and biguanides |
| CN105399661A (zh) * | 2015-12-14 | 2016-03-16 | 华东师范大学 | 2,6-二溴甲基吡啶的制备方法 |
| US11178872B2 (en) | 2016-05-09 | 2021-11-23 | Nippon Soda Co., Ltd. | Cyclic amine compound and pest control agent |
| KR20190129867A (ko) | 2017-02-17 | 2019-11-20 | 트레베나, 인코포레이티드. | 5-원 아자-헤테로고리 함유 델타-오피오이드 수용체 조절 화합물, 및 그의 사용 및 제조 방법 |
| EP3582783B1 (en) | 2017-02-17 | 2023-06-07 | Trevena, Inc. | 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same |
| WO2021030335A1 (en) * | 2019-08-12 | 2021-02-18 | Millendo Therapeutics, Inc. | A stereoisomerically pure nk-3 receptor antagonist and crystalline forms thereof |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU506399B2 (en) | 1975-12-30 | 1980-01-03 | Showa Denko Kabushiki Kaisha | 3-(2-aryl-2-propyl) ureas |
| IN148482B (pt) | 1977-06-03 | 1981-03-07 | Pfizer | |
| GB9321557D0 (en) | 1992-11-03 | 1993-12-08 | Zeneca Ltd | Carboxamide derivatives |
| IL111960A (en) | 1993-12-17 | 1999-12-22 | Merck & Co Inc | Morpholines and thiomorpholines their preparation and pharmaceutical compositions containing them |
| CN1067683C (zh) | 1993-12-29 | 2001-06-27 | 默克·夏普-道姆公司 | 取代的吗啉衍生物及其作为治疗剂的用途 |
| TW385308B (en) | 1994-03-04 | 2000-03-21 | Merck & Co Inc | Prodrugs of morpholine tachykinin receptor antagonists |
| GB9714129D0 (en) * | 1997-07-04 | 1997-09-10 | Pfizer Ltd | Azetidines |
| US5972938A (en) | 1997-12-01 | 1999-10-26 | Merck & Co., Inc. | Method for treating or preventing psychoimmunological disorders |
| EP1192952A3 (en) | 2000-09-28 | 2003-03-26 | Pfizer Products Inc. | Combination, for treating depression and anxiety, containing an NK-3 receptor antagonist and a CNS penetrant NK-1 receptor antagonist |
| US6531597B2 (en) | 2001-02-13 | 2003-03-11 | Hoffmann-La Roche Inc. | Process for preparation of 2-phenyl acetic acid derivatives |
| BR0311425A (pt) * | 2002-05-31 | 2005-03-15 | Takeda Pharmaceutical | Composto, pró-droga, método para preparar o composto, álcool oticamente ativo, e amina oticamemte ativa, e para prevenir e/ou tratar anormalidades ou doenças, medicamento, e, uso do composto ou de uma pró-droga deste |
| WO2005002577A1 (en) | 2003-07-03 | 2005-01-13 | F. Hoffmann-La Roche Ag | Dual nk1/nk3 antagonists for treating schizophrenia |
| US7468437B2 (en) * | 2003-09-30 | 2008-12-23 | Merck & Co., Inc. | Phenyl pyrrolidine ether tachykinin receptor antagonists |
| CA2552965A1 (en) * | 2004-01-14 | 2005-07-28 | Takeda Pharmaceutical Company Limited | Carboxamide derivative and use thereof |
| US7138423B2 (en) * | 2004-07-20 | 2006-11-21 | Bristol-Myers Squibb Company | Arylpyrrolidine derivatives as NK-1 /SSRI antagonists |
| KR100939347B1 (ko) | 2005-07-20 | 2010-01-29 | (주)카이로드 | 광학적으로 순수한 (ｓ)-3-히드록시 피롤리딘의 제조방법 |
-
2008
- 2008-07-29 MX MX2010001080A patent/MX2010001080A/es active IP Right Grant
- 2008-07-29 RU RU2010106974/04A patent/RU2010106974A/ru unknown
- 2008-07-29 ES ES08786547T patent/ES2367464T3/es active Active
- 2008-07-29 BR BRPI0815658-1A2A patent/BRPI0815658A2/pt not_active IP Right Cessation
- 2008-07-29 CA CA2695211A patent/CA2695211A1/en not_active Abandoned
- 2008-07-29 CN CN200880102376A patent/CN101778837A/zh active Pending
- 2008-07-29 KR KR1020107004881A patent/KR101167774B1/ko not_active Expired - Fee Related
- 2008-07-29 JP JP2010519428A patent/JP2010535733A/ja active Pending
- 2008-07-29 EP EP08786547A patent/EP2185540B1/en not_active Not-in-force
- 2008-07-29 AU AU2008285718A patent/AU2008285718A1/en not_active Abandoned
- 2008-07-29 WO PCT/EP2008/059908 patent/WO2009019163A1/en not_active Ceased
- 2008-07-29 AT AT08786547T patent/ATE517100T1/de active
- 2008-08-04 US US12/185,157 patent/US8012998B2/en not_active Expired - Fee Related
- 2008-08-04 CL CL2008002293A patent/CL2008002293A1/es unknown
- 2008-08-05 PE PE2008001308A patent/PE20090898A1/es not_active Application Discontinuation
- 2008-08-05 AR ARP080103406A patent/AR067808A1/es unknown
- 2008-08-06 TW TW097129930A patent/TW200916456A/zh unknown
-
2010
- 2010-01-18 IL IL203363A patent/IL203363A/en not_active IP Right Cessation
- 2010-01-28 ZA ZA201000676A patent/ZA201000676B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009019163A1 (en) | 2009-02-12 |
| IL203363A (en) | 2013-03-24 |
| CL2008002293A1 (es) | 2009-05-29 |
| AU2008285718A1 (en) | 2009-02-12 |
| CA2695211A1 (en) | 2009-02-12 |
| ATE517100T1 (de) | 2011-08-15 |
| ZA201000676B (en) | 2010-10-27 |
| RU2010106974A (ru) | 2011-09-20 |
| US8012998B2 (en) | 2011-09-06 |
| KR20100045502A (ko) | 2010-05-03 |
| EP2185540A1 (en) | 2010-05-19 |
| TW200916456A (en) | 2009-04-16 |
| EP2185540B1 (en) | 2011-07-20 |
| KR101167774B1 (ko) | 2012-07-24 |
| AR067808A1 (es) | 2009-10-21 |
| JP2010535733A (ja) | 2010-11-25 |
| PE20090898A1 (es) | 2009-07-13 |
| MX2010001080A (es) | 2010-03-01 |
| US20090042896A1 (en) | 2009-02-12 |
| ES2367464T3 (es) | 2011-11-03 |
| CN101778837A (zh) | 2010-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0815658A2 (pt) | Aril-éter pirrolidina como antagonistas do receptor nk3 | |
| HUS2200033I1 (hu) | CGRP receptor antagonisták | |
| BRPI0815674A2 (pt) | Aril-éter de pirrolidina como antagonista de receptor de nk3 | |
| BRPI0821141A2 (pt) | Derivados de heteroarila como antagonistas do receptor de orexina | |
| DK2821407T3 (da) | Piperidinoncarboxamidazaindan-cgrp receptorantagonister | |
| BRPI0909157A2 (pt) | compostos heterocíclicos como antagonistas de receptores de adenosina | |
| CR10926A (es) | Nuevas 2-aminooxazolinas como ligandos taar1 | |
| EP2350060A4 (en) | Melanocortin receptor AGONISTS | |
| BRPI0810462A2 (pt) | Derivados de quinolina-carboxamida como antagonistas de p2y12 | |
| BRPI0913930A2 (pt) | antagonistas de receptores de prostaglandinas d2 | |
| BRPI1013821A2 (pt) | piridinas substituídas como antagonistas de ccr3. | |
| DK2448963T3 (da) | T-celle receptorer | |
| CR20130271A (es) | Antagonistas de mdm2 de espiro-oxindol | |
| BRPI0919844A2 (pt) | compostos de azaindazol como antagonistas do receptor ccr1 | |
| BRPI1013856A2 (pt) | terapias à base de ligantes de receptores quimiossensíveis | |
| BRPI0814806A2 (pt) | Pirazinas substituídas como antagonistas de cb1 | |
| BRPI1016189A2 (pt) | compostos de 4-azetidinil-1-fenil-ciclohexano antagonistas de ccr2 | |
| BRPI0717023A2 (pt) | Tiazol pirazolopirimidina como antagonistas do receptor de crf1 | |
| BRPI0717937A2 (pt) | Compostos de pirazona como antagonistas do receptor mineralocorticóide | |
| BRPI0910118A2 (pt) | antagonistas de receptores do glucagon | |
| HRP20150167T1 (xx) | Spojevi kao antagonisti bradikinina-b1 | |
| BRPI0815948A2 (pt) | "compostos heterocíclicos como antagonistas de receptorncrth2" | |
| HUE063115T2 (hu) | Kiméra I-es típusú IL-1 receptor antagonisták | |
| EP2176386A4 (en) | UPPER CARBURETOR | |
| BR112012003701A2 (pt) | "novos antagonistas de quinolina-hepcidina" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |